Wordt geladen...
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
INTRODUCTION: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer patients to describe clinical outcomes of those who, despite progression of the disease (PD), maintained trastuzumab for multiple chemotherapy lines. We also compared survival of these patients with t...
Bewaard in:
Hoofdauteurs: | , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2008
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2575533/ https://ncbi.nlm.nih.gov/pubmed/18631394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2119 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|